• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EUROSETS S.R.L. ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EUROSETS S.R.L. ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number US5062
Device Problem Infusion or Flow Problem (2964)
Patient Problems Hypoxia (1918); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/15/2021
Event Type  Injury  
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Event Description
It was reported that the patient was placed on extracorpeal membrane oxygenation (ecmo) in the catheterization lab.Upon initiation of support, the pre-oxygenation pressures of the eurosets oxygenator exceeded 350 mmhg.Despite this, flow was unable to surpass 3.5 liters per minute, no matter how high the centrimag¿s rotations per minute were increased.Pressure alarms sounded and were also displayed.The eurosets oxygenator was exchanged and support to the patient was resumed.
 
Event Description
The issue with the oxygenator occurred immediately after initiation of support.The patient had been minimally hypoxic prior to initiating extracorporeal life support (ecls) with a different cannulation strategy on the new circuit/ euroset.The patient was in a hypoxic state despite the fio2 on the vent being increased to 100%.The hypoxemia became worse on the new circuit/ euroset until the euroset was changed out.The oxygenator was exchanged for another eurosets oxygenator.
 
Manufacturer Narrative
No further information was provided.A supplemental report will be submitted once the manufacturer¿s investigation is completed.
 
Manufacturer Narrative
Manufacturer's investigation conclusion: a specific cause for the flow issue could not conclusively be determined through this evaluation.The eurosets amg (advanced membrane gas exchange) pmp (polymethylpentene) oxygenator, lot number 7081108, was returned to the abbott facility in (b)(6), ma, where a visual inspection was performed.Segments of tubing were secured to the blood inlet and blood outlet ports with zip ties and pigtails were secured to both the blood inlet and outlet ports.A segment of screen tubing was connected to the gas inlet port.Visual inspection of the oxygenator revealed no obvious damage to the external housing, ports, or fibers.No blood was observed within the top or bottom orange housing.The production documentation for amg pmp oxygenator, lot # 7081108, was reviewed by the external manufacturer (eurosets) and showed that all tests from the production process were compliant with the technical specifications.The specific root cause of the reported issue could not be conclusively determined.The eurosets amg pmp instructions for use (ifu) is currently available.Under the list of precautions, the ifu cautions that a strict anticoagulation protocol should be followed and anticoagulation should be routinely monitored during all procedures.The benefit of extracorporeal support must be weighed against the risk of systemic anticoagulation and must be assessed by the prescribing physician.Adequate heparinization must be maintained before and during bypass.Under the list of warnings, the ifu warns that during the extracorporeal circulation (ecc) a backup oxygenator is necessary and also warns that the extracorporeal circulation has to be carefully and continuously checked.Under the section titled, ¿bypass start¿, the ifu contains a subsection on blood gas monitoring and explains how to adjust the relevant parameters based on the patient¿s blood gas values.Under the section titled ¿oxygenator replacement¿, this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.No further information was provided.The manufacturer is closing the file on this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCED MEMBRANE GAS EXCHANGE PMP STERILE
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
EUROSETS S.R.L.
strada statale 12, n°143
medolla, modena 41036
IT  41036
Manufacturer (Section G)
EUROSETS S.R.L.
strada statale 12, n°143
medolla, modena 41036
IT   41036
Manufacturer Contact
bob fryc
6035 stoneridge drive
pleasanton, CA 94588
7818528204
MDR Report Key12623699
MDR Text Key282120327
Report Number3003752502-2021-00011
Device Sequence Number1
Product Code DTZ
UDI-Device Identifier08034013782020
UDI-Public08034013782020
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K141492
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 02/28/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2024
Device Model NumberUS5062
Device Catalogue NumberUS5062
Device Lot Number7081108F0265
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/19/2021
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/16/2021
Initial Date FDA Received10/13/2021
Supplement Dates Manufacturer Received11/05/2021
02/26/2022
Supplement Dates FDA Received12/02/2021
02/28/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured04/01/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age35 YR
Patient SexMale
Patient Weight128 KG
Patient EthnicityNon Hispanic
Patient RaceWhite
-
-